Posted by on Jul 21, 2019 in Blog, Erectile dysfunction, Prostate cancer, Urinary incontinence | 0 comments

The prostate is a tiny gland in a crowded part of the body. It is situated right below the bladder, right next to the rectum,

Image from the National Cancer Institute

near the blood and nerve supply for the penis.

Unfortunately, one in nine men will get cancer in this tiny gland. According to the UsToo International prostate cancer website, nearly 3 million men in the US are living with prostate cancer.

Factors Affecting Type of Prostate Cancer Treatment

Gleason score

prostate cancer treatmentProstate cancer treatment depends on several factors. Men should find out first, what grade their cancer is. Grade 1 has the lowest risk and means that the cells of the cancer look similar to normal prostate tissue. A grade of 5 means that the cancer looks nothing like normal tissue. The pathologist looks for the two most common types of cells. So if you have most cells that are 1 and the next most common 3, your total Gleason score is 4 (1+3). The higher the score, the more aggressive your cancer is. Gleason score of 1 through 6 is a low risk score, 7 is intermediate risk, and a Gleason of 8 to 10 is a high risk cancer that is more likely to spread.

Physical features of the cancer

Another feature of an aggressive cancer is a palpable (meaning it can be felt by the doctor) nodule. Two other physical features indicate aggressiveness 1) if the cancer has grown around the nerves in the prostate and 2) if the cancer has grown outside the prostate gland capsule.

PSA density

PSA density is a measure of the amount of PSA in a man’s blood compared to the size or volume of the prostate. If the PSA density is .15 or lower, the cancer is more likely to be less aggressive.

Number of cancerous cores

While doing a biopsy, the urologist usually takes 12 core samples from the prostate. If 3 or fewer are cancerous, this is a sign that your cancer is of lower risk.

Low risk versus high risk cancer and treatment

Low risk

Treatment depends on the extent and invasiveness of the cancer. For men with low risk prostate cancer, active surveillance has become much more popular. Recent research looking at the use of the various treatments for prostate cancer has shown an upsurge of men choosing active surveillance. The study of men diagnosed with low-risk prostate cancer between 2010 and 2015 showed that over 40 percent chose active surveillance and during the same 5 year period there a was a drop in radical prostatectomies, from 47 to 31 percent and in radiotherapy from 38 to 27 percent.

High risk

prostate cancer treatmentTreatment also includes radiation therapy (either external beam or brachytherapy), radical prostatectomy, and androgen deprivation therapy (ADT). These treatments for prostate cancer can cause significant problems for men. Called “side effects” in medical jargon, these changes can include incontinence, erectile dysfunction (ED) and bowel disruption. Radiation therapy can cause bleeding of the bladder and rectum. Androgen depravation therapy (ADT) or chemical castration is often required in treatment, causing loss of libido and emotional changes including anger and depression.

“A Couple’s Disease”

The side effects have led to prostate cancer being referred to as a “couple’s disease.” One survivor said in an interview for the Prostate Cancer Foundation website, “Nobody talks about sexual rehabilitation. That’s the dirty secret after prostate cancer surgery.”

Research supports this survivor’s feelings. A study published in March 2017 measured quality of life using the Prostate Cancer Symptom Indices.  1114 men diagnosed between January 2011 and June 2013 participated in the study. Twenty-seven percent underwent active surveillance, 41 percent chose radical prostatectomy as their treatment, 22 percent chose external beam radiotherapy, and 10 percent brachytherapy (radiation seeds). Surveys were taken at baseline (before treatment began) and at 3  6, and 24 months after their treatment. The answers of those who chose active surveillance were compared to those who chose treatment.

At 24 months, poor sexual function was reported by 57 percent of men who had normal sexual function before their surgery. For those who had the different radiotherapies, 27 percent of those treated with external beam and 34 percent with brachytherapy experienced poor sexual function. That is a significant number of men, and their intimate partners, left dealing with an enormous change in their lives.

In another study, researchers interviewed  19 men under 65 who had radical prostatectomy as their treatment. The side effect of sexual dysfunction impacted the men’s self-image and self esteem. The men felt that they had paid a price for survival. They also worried that death was just around the corner.  Another study found that patients on ADT experienced “significant declines” in quality of life and on intimate relationships when comparing baseline, 3 and 6 months on the treatment.

Before Treatment Discussions of Sexual Function and Rehabilitation

Though sexual relations are private and a difficult subject to discuss, it is essential to actively address this issue with yourprostate cancer treatment intimate partner and your physician. If your physician is not willing to communicate about all the changes that can possibly occur and how to deal with them, or does not have help in place for survivors and their partners, this is a red flag for you to seek a second opinion prior to treatment.

Finding help and support for both you and your partner is critical before and after treatment. US Too International is an organization that provides information as well as support. “Through our support groups, online support services, newsletters, educational materials and events, Us TOO will help transform resignation into determination and fear into Hope.”